Research Grant Applications

The Ehlers-Danlos Society Research Grants

Please note that The Ehlers-Danlos Society offers a maximum of 5% uplift of the value of the grant for indirect costs.

Research Grants

The Ehlers-Danlos Society aspires to offer grants annually, with calls for clinical research proposals early in the year and for basic science later in the year. We will also offer grants of varying value to reflect the different nature of researcher requirements, including microgrants. Examples of our recent funding are available to see here.

The 2021 $1 Million Molecular studies in hEDS/HSD grant round closed on April 9, 2021, and details of the next grant round will be announced in early 2022.

The Society aims to award around nine grants of up to $5000 each in the Spring Microgrant Round. Applicants should review the information on the grant announcement but typically, though not exclusively, these awards are given to assist researchers undertaking small study hypothesis testing, activities such as surveys, or collation and analysis of existing data, for example, in the areas of Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD).

Spring Microgrant Round

Announcement date – February 5, 2020

Deadline for submissions – June 30, 2020

This round is now closed for submissions. 

2020 Clinical Research Major Grants


The Clinical Research round will award grants ranging between $50,000 to $150,000 from a total fund of $400,000. These grants aim to support studies likely to require 1-3 years to complete and to cover the costs for researchers and study equipment. All areas of health and social care, and education applicable to our research priorities that have a direct impact on care in the Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) will be considered.

Clinical Research Grants Timeline:

  • Announcement Date – 9 March, 2020
  • Submission Deadline – 30 June, 2020
  • Award Notification – 16 October, 2020

This round is now closed for submissions. 

In addition to the earlier Spring Microgrants, The Society will be awarding up to an additional nine grants of up to $5000 each in the next microgrant round. Typically, though not exclusively, these awards are given to assist researchers undertaking small study hypothesis testing, activities such as surveys, or collation and analysis of existing data, for example, in the areas of Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD).

Fall Microgrants Round

Announcement date – November 30, 2020

Deadline for submissions – February 28, 2021

This round is now closed for submissions. 

APPLICATIONS NOW CLOSED

The Basic Research round will award grants ranging between $50,000 to $150,000 from a total fund of $400,000. the grants aim to support studies likely to require 1-3 years to complete and to cover the costs for researchers and study equipment. All research topics aiming to improve our understanding of pathophysiological mechanisms underlying Ehlers-Danlos syndromes (EDS) and hypermobility spectrum disorders (HSD) will be considered, including e.g. :

  • Gene and mutation discovery
  • Basic and translational research using different animal and cellular models
  • Genomic, transcriptomic, proteomic, and metabolic studies
  • Pathophysiological mechanisms of EDS

Basic Science Grants Timeline:

  • Announcement Date – 18 January, 2021
  • Submission Deadline – 28 February, 2021

This round is now closed for submissions. 

APPLICATIONS NOW CLOSED

The Ehlers-Danlos Society is pleased to announce a round of grants for research into the molecular basis of disease in hEDS/HSD from an available fund of $1 million.

The grant amount may be up to a maximum of $250,000 for studies that may take six months to three years to complete, on topics such as:
• Gene and mutation discovery
• Studies in animals or in vitro systems
• Genomic, transcriptomic, proteomic, or metabolic studies
• Pathophysiological mechanisms in hEDS/HSD
• Diagnostic markers

For studies requiring serum or plasma, the EDS Society Biobank anticipates having serum and plasma samples within the next few months from several hundred individuals meeting the 2017 criteria for hEDS.

  • Announcement Date – January 15, 2021
  • Submission Deadline – April 9, 2021
  • Award Notification – July 2, 2021

This round is now closed for submissions.